BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...

Please provide your email address to receive an email when new articles are posted on . Researchers have proposed a machine-learning algorithm for personalized treatment selection in patients with ...

Researchers have developed a new AI-powered algorithm to help understand how different cells organize themselves into particular tissues and communicate with one another. Researchers from Children's ...

Omitting race and ethnicity from colorectal cancer (CRC) recurrence risk prediction models could decrease their accuracy and fairness, particularly for minority groups, potentially leading to ...

Helsinki, Finland - A new risk model developed by European researchers is able to accurately predict vascular events, including stroke, MI, and vascular death, in patients with existing clinical ...

Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...